Hutchison-Gilford Progeria Syndrome – A new treatment strategy and the role of prelamin A in oncogenesis
Abstract
Prelamin A, a CaaX-protein is a key structural protein of the inner nuclear lamina, a meshwork lining the inner
nuclear envelope. Farnesylated prelamin A is cleaved just upstream of the farnesylcysteine residue to produce
mature lamin A. We generated Zmpste24 knockout mice and documented a striking accumulation of
farnesylated and methylated prelamin A in cells. Zmpste24 knockout cells exhibit premature senescence and
misshapen cell nuclei. Zmpste24 knockout mice show slow growth, hair loss, micrognathia, bone fractures,
muscle weakness, and premature death. These phenotypes are similar to those in HGPS. HGPS is caused by a
LMNA point mutation that leads to the deletion of 50 amino acids in the carboxyl terminus of prelamin A
(eliminating the ZMPSTE24 cleavage site and preventing formation of mature lamin A). Consequently, a mutant
farnesylated and methylated prelamin A accumulates at the nuclear rim in HGPS cells, interfering with the
nuclear lamina and causing misshapen cell nuclei.
Specific Aim and Results of Paper 1: To define the importance of ICMT in the pathogenesis and
treatment of progeria. In this project we bred Zmpste24 knockout mice with mice harboring a hypomorphic
(reduced expression) allele of Icmt. We found that these mice where protected from most aspects of progeroid
disease. They had an increased survival, lack of osteoporosis, and increased strength. Icmt inhibition in cells
derived from Zmpste24 KO mice and cells from human progeria patients also showed increased proliferative
and somatrophic activity, without affecting the frequency of nuclear shape abnormalities which is one of the
hallmark phenotypes of progeria.
Specific Aim and Results of Paper 2: To test the hypothesis that prelamin A is a tumor suppressor. We
bred Zmpste24 knockout mice with mice expressing a Cre-inducible endogenous oncogenic K-RAS and B-Raf
alleles (K-RASLSL/+ and B-RafCA). Groups of mice where then allowed to inhale a Cre- adenovirus to activate
the expression of oncogenic K-RASG12D/+ and B-RafV600E in lung cells (these mice normally develop lung
adenomas to adenocarcinoma without metastases). 10 and 8 weeks post inhalation mice were euthanized and
lungs where prepared for routine histology. Surprisingly, Zmpste24-deficiency had no impact on the
development K-RASG12D/+ and B-RafV600E driven tumor except for a reduction in grade. Furthermore,
fibroblasts derived from the same mice could be readily transformed and proliferated at the same rate as
Zmpste24 competent cells. Finally, K-RASG12D/+, B-RafV600E Zmpste24-fibroblasts had significantly reduced
basement membrane invasiveness.
Parts of work
I. Targeting isoprenylcysteine methylation ameliorates disease in a mouse model of progeria.
Ibrahim MX, Sayin VI, Akula MK, Liu M, Fong LG, Young SG, Bergo MO.
Science. 2013 Jun 14;340(6138):1330-3. doi: 10.1126/science.1238880. Epub 2013 May 16.
::PMID::23686339 II. Prelamin A inhibits K-RAS and B-Raf induced invasion but is dispensable for tumorgenesis.
Manuscript.
Ibrahim MX, Sayin VI, Bergo MO.
Degree
Doctor of Philosophy (Medicine)
University
University of Gothenburg. Sahlgrenska Academy
Institution
Institute of Medicine. Department of Molecular and Clinical Medicine
Disputation
Torsdagen den 15 maj 2014, kl.9.00, Hörsal Ivan Östholm, Medicinaregatan 13(LNC)
Date of defence
2014-05-15
mohamed.ibrahim@gu.se
Date
2014-04-25Author
Ibrahim, Mohamed
Keywords
progeria
cancer
Publication type
Doctoral thesis
ISBN
978-91-628-9043-8
978-91-628-9014-8
Language
eng